Amgen
AMGN
|
NASDAQ
|
31 Followers
Fair Price
$099.99
Fair Price Index
The fair price of a share represents the true value of the company's share based on its financial condition and performance. Unlike the current market price, which can fluctuate depending on the mood of the market, the fair price provides us with a better understanding of whether the share is truly advantageous.
Overvalued by 6.5%
To display the fair price of a share, you need to be a member of Bulios Black.
Profile
Feed
Read More
Amgen (AMGN): a hidden player in the GLP-1 sector with great potential
The GLP-1 weight loss drugs market is one of the fastest growing segments of the healthcare industry and could reach a value of $200 billion by 2031. So far, Eli Lilly (LLY) and Novo Nordisk (NVO) dominate the market, but their shares are trading at extremely high earnings multiples. Amgen $AMGN may become a...
Read more
Read More
Amgen and its MariTide programme: Is the stock drop worth the buying opportunity?
Amgen $AMGN recently disclosed the results of its obesity treatment candidate MariTide, which has completed Phase II clinical trials. Although the stock responded with a drop of more than 12%, it closed the day with only a 4.7% decline. The market viewed the results as less promising compared to...
Read more
Zobrazit další komentáře
Overall, the industry has a lot of potential right now. I'm probably most interested in $NVO so far and the stock is pretty down right now, so I'm thinking about buying.
I'd like to buy $LLY stock, but the valuation is too high right now.